TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,281 | -87.0% | 10,684 | -86.8% | 0.15% | -87.3% |
| Q2 2023 | $1,269,352 | -6.3% | 80,799 | -1.7% | 1.17% | -9.6% |
| Q1 2023 | $1,355,233 | +5.6% | 82,235 | 0.0% | 1.30% | +5.6% |
| Q4 2022 | $1,283,000 | +13.1% | 82,235 | -6.0% | 1.23% | +3.7% |
| Q3 2022 | $1,134,000 | -6.1% | 87,460 | +1.6% | 1.18% | -1.3% |
| Q2 2022 | $1,208,000 | +4.8% | 86,045 | +6.9% | 1.20% | +25.3% |
| Q1 2022 | $1,153,000 | +21.6% | 80,490 | +15.7% | 0.96% | +18.9% |
| Q4 2021 | $948,000 | +33.5% | 69,550 | +60.5% | 0.80% | +30.9% |
| Q3 2021 | $710,000 | +312.8% | 43,320 | +324.3% | 0.62% | +310.0% |
| Q2 2021 | $172,000 | – | 10,210 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |